Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives... Show more
Celanese Corporation stands as a global leader in specialty chemicals and engineered materials, with a strong emphasis on acetyl products—key building blocks for vinyl acetate monomer (VAM) and acetic acid—and high-performance polymers used in automotive, electronics, and consumer applications. Its competitive edge derives from a globally integrated production network that delivers asset-led cost advantages through debottlenecks, brownfield expansions, and strategic joint ventures, such as a U.S. methanol facility. The company's shift toward higher-margin specialty segments positions it well for medium-term growth, even as commodity cycles fluctuate. Market share in engineered materials benefits from innovation in sustainable solutions and onshoring trends, though rivals like DuPont and Eastman challenge in select niches. Overall, Celanese's focus on portfolio optimization and operational flexibility supports resilient positioning in a consolidating chemicals landscape.
The Q1 2026 earnings release on May 6 represents a pivotal near-term event, where management may refine 2026 outlook on EPS growth of $1-2 and divestiture proceeds targeting $1 billion, influencing investor views on capital allocation. Recent price hikes—acetyls in March, engineered materials effective April 1, and polyamides from February—underscore efforts to recapture margins amid soft demand, potentially boosting sentiment if passed through successfully. Analyst activity has turned constructive, with April boosts from Citigroup (to $84 Buy), Wells Fargo (to $75 Overweight), and others, alongside upgrades from Vertical Research and Jefferies earlier in the year. These revisions suggest growing confidence in cost discipline, though consensus remains Hold with a $63.65 average target, reflecting balanced expectations. Potential asset sales and plant optimizations could accelerate deleveraging, a critical factor for equity holders.
The chemicals sector confronts a downcycle in 2026, marked by subdued demand, overcapacity, and cutbacks, with peers planning further capacity reductions. Celanese, as a late-cycle play, exhibits acute sensitivity to global GDP expansion—forecast at 3.1%—and industrial rebound in autos and electronics. Elevated interest rates pressure its balance sheet, prompting deleveraging via free cash flow and sales, while volatile commodity inputs are mitigated by pricing discipline. Geopolitical tensions, including supply disruptions, favor Celanese's integrated footprint for continuity, and regulatory pushes for sustainability align with its specialty evolution. Broader inflation moderation could ease input costs, supporting margin sustainability.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality for timely insights. Traders can leverage this engine to inform strategies on assets like CE amid volatile markets.
Looking to 2026 and beyond, Celanese prioritizes cost structure improvements, targeting $50-70 million in savings alongside $650-750 million in free cash flow to fund deleveraging and dividends. A $1 billion divestiture program focuses the portfolio on high-return specialties, potentially driving $1-2 EPS accretion while navigating downcycle pressures. Long-term drivers include market expansion in sustainable materials, technology shifts toward advanced polymers, and margin gains from pricing and efficiency. Competitive threats from low-cost producers loom, but onshoring and innovation cycles offer tailwinds. Consensus analyst expectations, with Hold ratings and mid-$60s targets, hinge on execution amid uncertain GDP and rates trajectories. Regulatory emphasis on green chemistry could accelerate transitions, shaping sustained positioning.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a producer of industrial chemicals
Industry ChemicalsMajorDiversified
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PSCH | 49.22 | 0.59 | +1.22% |
| Invesco S&P SmallCap Health Care ETF | |||
| GGLS | 5.91 | 0.04 | +0.74% |
| Direxion Daily GOOGL Bear 1X ETF | |||
| DLY | 13.75 | 0.01 | +0.07% |
| DoubleLine Yield Opportunities Fund | |||
| IYW | 243.37 | -9.91 | -3.91% |
| iShares US Technology ETF | |||
| QTAC | 24.33 | -1.25 | -4.88% |
| Q3 All-Season Tactical Advantage ETF | |||
A.I.dvisor indicates that over the last year, CE has been closely correlated with DOW. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if CE jumps, then DOW could also see price increases.
| Ticker / NAME | Correlation To CE | 1D Price Change % |
|---|---|---|
| CE | 100% | -3.22% |
| CE (4 stocks) | 93% Closely correlated | -1.53% |
| Chemicals: Major Diversified (18 stocks) | 79% Closely correlated | -1.68% |
The RSI Indicator for CE moved out of oversold territory on June 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In of the 31 cases the stock moved higher. This puts the odds of a move higher at .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CE advanced for three days, in of 299 cases, the price rose further within the following month. The odds of a continued upward trend are .
CE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on June 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CE as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CE turned negative on June 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CE entered a downward trend on June 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.342) is normal, around the industry mean (9.271). P/E Ratio (6.963) is within average values for comparable stocks, (32.752). Projected Growth (PEG Ratio) (1.742) is also within normal values, averaging (20.317). CE has a moderately low Dividend Yield (0.002) as compared to the industry average of (0.035). P/S Ratio (0.575) is also within normal values, averaging (2.066).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.